Wagner B, Gerletti P, Furst P, Keuth O, Bernsmann T, Martin A
Nat Food. 2023; 3(11):921-932.
PMID: 37118216
DOI: 10.1038/s43016-022-00623-7.
Pintori N, Caria F, De Luca M, Miliano C
Int J Mol Sci. 2023; 24(6).
PMID: 36982327
PMC: 10048857.
DOI: 10.3390/ijms24065251.
Britch S, Craft R
J Pain. 2022; 24(1):98-111.
PMID: 36122809
PMC: 9789172.
DOI: 10.1016/j.jpain.2022.09.002.
Louis-Gray K, Tupal S, Premkumar L
Int J Mol Sci. 2022; 23(17).
PMID: 36077412
PMC: 9456209.
DOI: 10.3390/ijms231710016.
Walsh K, McKinney A, Holmes A
Front Pharmacol. 2021; 12:777804.
PMID: 34916950
PMC: 8669157.
DOI: 10.3389/fphar.2021.777804.
Safety and tolerability of escalating cannabinoid doses in healthy cats.
Kulpa J, Paulionis L, Eglit G, Vaughn D
J Feline Med Surg. 2021; 23(12):1162-1175.
PMID: 33769105
PMC: 8637357.
DOI: 10.1177/1098612X211004215.
Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.
Petrunich-Rutherford M, Calik M
Adv Exp Med Biol. 2021; 1297:97-109.
PMID: 33537939
DOI: 10.1007/978-3-030-61663-2_7.
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs.
Vaughn D, Kulpa J, Paulionis L
Front Vet Sci. 2020; 7:51.
PMID: 32118071
PMC: 7029731.
DOI: 10.3389/fvets.2020.00051.
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry.
Ueberall M, Essner U, Mueller-Schwefe G
J Pain Res. 2019; 12:1577-1604.
PMID: 31190969
PMC: 6535492.
DOI: 10.2147/JPR.S192174.
Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion.
Boggs D, Peckham A, Boggs A, Ranganathan M
Ment Health Clin. 2018; 6(6):277-284.
PMID: 29955482
PMC: 6007535.
DOI: 10.9740/mhc.2016.11.277.
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ-Tetrahydrocannabinol.
Boggs D, Nguyen J, Morgenson D, Taffe M, Ranganathan M
Neuropsychopharmacology. 2017; 43(1):142-154.
PMID: 28875990
PMC: 5719112.
DOI: 10.1038/npp.2017.209.
Cannabidiol-Δ-tetrahydrocannabinol interactions on acute pain and locomotor activity.
Britch S, Wiley J, Yu Z, Clowers B, Craft R
Drug Alcohol Depend. 2017; 175:187-197.
PMID: 28445853
PMC: 5499986.
DOI: 10.1016/j.drugalcdep.2017.01.046.
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe M, Creehan K, Vandewater S
Br J Pharmacol. 2014; 172(7):1783-91.
PMID: 25425111
PMC: 4376456.
DOI: 10.1111/bph.13024.
Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety.
Harte-Hargrove L, Dow-Edwards D
Behav Brain Res. 2012; 231(1):48-59.
PMID: 22421367
PMC: 4212817.
DOI: 10.1016/j.bbr.2012.02.048.
Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T
Psychopharmacology (Berl). 2011; 218(2):443-57.
PMID: 21667074
DOI: 10.1007/s00213-011-2342-0.
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt J, Molleman A, Pertwee R, Parsons M
Br J Pharmacol. 2010; 160(3):712-23.
PMID: 20590574
PMC: 2931570.
DOI: 10.1111/j.1476-5381.2010.00791.x.
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann R, Gamage T, Warner J, Marshall E, Taylor N, Martin B
Drug Alcohol Depend. 2008; 94(1-3):191-8.
PMID: 18206320
PMC: 2279017.
DOI: 10.1016/j.drugalcdep.2007.11.017.
Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel S, Wiley J, Yang R, Bridgen D, Long K, Lichtman A
Psychopharmacology (Berl). 2006; 186(2):226-34.
PMID: 16572263
DOI: 10.1007/s00213-006-0356-9.
Behavioral effects of prolonged administration of delta 9-tetrahydrocannabinol in the rat.
Stiglick A, Kalant H
Psychopharmacology (Berl). 1983; 80(4):325-30.
PMID: 6312481
DOI: 10.1007/BF00432114.
Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
Zuardi A, Shirakawa I, Finkelfarb E, Karniol I
Psychopharmacology (Berl). 1982; 76(3):245-50.
PMID: 6285406
DOI: 10.1007/BF00432554.